GTCM
TIL icon

Gyon Technologies Capital Management’s Instil Bio TIL Stock Holding History

Gyon Technologies Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-591
Closed -$202K – 557
2021
Q4 		$202K Buy
+591
New +$228K 0.04% 525

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Gyon Technologies Capital Management's TIL Position: Q1 2022 in Review

Gyon Technologies Capital Management sold out of Instil Bio (TIL) in Q1 2022, closing a stake of 591 shares — an estimated $202K sold.

Gyon Technologies Capital Management first reported a position in TIL in Q4 2021 and held it in 1 quarter. The position peaked at $202K in Q4 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q1 2022.

  • Gyon Technologies Capital Management reported no remaining Instil Bio position as of Q1 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 591 Instil Bio shares in Q1 2022, an estimated $202K.
  • Gyon Technologies Capital Management first reported a position in Instil Bio in Q4 2021 and held it in 1 quarter.
  • Gyon Technologies Capital Management's Instil Bio position peaked at $202K in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q1 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2022, filed 12 May 2022.